Health AI Central
Peer-Reviewed Publication
Oncologist2026October 1, 2026Journal Article

Precision Oncology at Speed: Workflow Design Determines Clinical Utility in Rapid Molecular Testing for Lung Cancer.

Brandon S Sheffield1,2, Katherina Baranova2,3, Parneet Cheema2, Miriam A Bredella4, Champica Nicholas1,2, Ibiayi Dagogo-Jack5, Jochen K Lennerz6
1Division of Advanced Diagnostics, William Osler Health System, Brampton, Canada.
2Osler Research Institute for Health Innovation, Brampton, Canada.
3London Health Sciences Centre (LHSC), London, Ontario, Canada.
4NYU Langone Health, Grossman School of Medicine, New York, NY, USA.
5Massachusetts General Hospital, Cancer Center, Boston, MA, USA.
6Natera, Austin, TX, USA.
PubMed DOI

Abstract

PURPOSE: Matching patients with effective targeted therapies requires timely molecular results, however the challenge today how to embed it into routine clinical workflows in ways that meaningfully affect patient-level treatment decisions. METHODS: Building on prior work, the authors systematically reviewed laboratory operations, interdepartmental coordination, and administrative processes from t…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.